Sunday, 16 June 2019

Market Survey News

  • China National Accord's R&D strategy begins to pay-off

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 31 May, 2013

    China National Accord Medicines Corporation utilized 2012 as a year to speed up the transformation and upgrade scientific development by implementing new medical reforms fostered by Chine...Read more

  • India's 127-year-old ayurvedic leader clocks $847 mn

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Growing on its legacy of 127 years, Dabur India clocked $847 million in 2012. The company is recognized for manufacturing traditional ayurvedic products that passes rigorous trials and au...Read more

  • What were Asia's Top 20 bio companies in 2012?

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording a double-digit growth of 11.07 percent over $139 billion of 2011. Aro...Read more

  • What were the top 20 global M&A transactions of 2012?

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing acute scarcity. This is making them seek out partners for mergers &am...Read more

  • Why did mergers & acquisitions plunge in APAC?

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 billion, which is about 10 percent lower than the number of deals struck ...Read more

  • Sanjiu Medical keeps focus on R&D

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 21 Jun, 2012

    Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medical instruments. The company also operates in pharmaceutical trading a...Read more

  • TCM leader Yunnan Baiyao rides on R&D strength

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    Yunnan Baiyao Group is expanding its forte in the domain of traditional Chinese medicines and is concentrating on strengthening its R&D base. Recognized as a leading traditional Chine...Read more

  • Baraclude tops Korea pharma products list

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Korea, whose pharma market is being fueled by an aging population with a rising demand for drugs, made it to the top three markets in Asia. China has the biggest market share, while Austral...Read more

  • Lipitor leads in Australia

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market followed by China. According to BioSpectrum Top20 survey for the Asia Pa...Read more

  • Guangzhou records a whopping growth of over 50%

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognized name in China, Guangzhou Pharmaceutical Holdings is principally eng...Read more

  • What are the key mergers & acquisitions of Q1 2013?

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The big players of the industry are thus looking for mergers & acqui...Read more

  • Australia is 3rd largest in terms of total company revenues

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2013

    Australia emerged as the third largest country in terms of the total revenue generated by companies during the calendar year 2012 in the recent BioSpectrum Asia Top 20 Survey. It leveraged ...Read more

  • What were the top 20 M&A deals in pharma and biotech sector in 2012?

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing acute scarcity. This is making them seek out partners for mergers &am...Read more

  • India ranks 2nd in terms of total company revenues

    Market Survey |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2013

    India emerged as the second largest country in terms of the total revenue generated by companies during the calendar year 2012 in the recent BioSpectrum Asia Top 20 Survey. It made several ...Read more

Podcast

 

Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls